Exceptional Response to Cabozantinib of Rapidly Evolving Brain Metastases of Renal Cell Carcinoma: A Case Report and Review of the Literature

被引：16

作者：

Ciccarese, Chiara ^{[1
]}

Iacovelli, Roberto ^{[1
]}

Mosillo, Claudia ^{[1
]}

Tortora, Giainpaolo ^{[1
]}

机构：

[1] Univ Verona, Azienda Osped Univ Integrata, Dept Med Oncol, Piazzale LA Scuro 10, I-37134 Verona, Italy

来源：

CLINICAL GENITOURINARY CANCER | 2018年 / 16卷 / 05期

关键词：

Antiangiogenic targeted agents; Blood-brain barrier penetration; Brain metastases; Complete response; RCC; PROGNOSTIC-FACTORS; TARGETED THERAPY; OPEN-LABEL; PHASE-II; SUNITINIB; SURVIVAL; CANCER; TRIAL;

D O I：

10.1016/j.clgc.2018.06.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：E1069 / E1071

页数：3

共 25 条

[1] Safety and Efficacy of Targeted Therapy for Renal Cell Carcinoma With Brain Metastasis [J].

Bastos, Diogo A. ;

Molina, Ana M. ;

Hatzoglou, Vaios ;

Jia, Xiaoyu ;

Velasco, Susanne ;

Patil, Sujata ;

Voss, Martin H. ;

Feldman, Darren R. ;

Motzer, Robert J. .

CLINICAL GENITOURINARY CANCER, 2015, 13 (01) :59-66

[2] Final results of the European Advanced Renal Cell Carcinoma Sorafenib (EU-ARCCS) expanded-access study: a large open-label study in diverse community settings [J].

Beck, J. ;

Procopio, G. ;

Bajetta, E. ;

Keilholz, U. ;

Negrier, S. ;

Szczylik, C. ;

Bokemeyer, C. ;

Bracarda, S. ;

Richel, D. J. ;

Staehler, M. ;

Strauss, U. P. ;

Mersmann, S. ;

Burock, K. ;

Escudier, B. .

ANNALS OF ONCOLOGY, 2011, 22 (08) :1812-1823

[3] Distribution of metastatic sites in renal cell carcinoma: a population-based analysis [J].

Bianchi, M. ;

Sun, M. ;

Jeldres, C. ;

Shariat, S. F. ;

Trinh, Q. -D. ;

Briganti, A. ;

Tian, Z. ;

Schmitges, J. ;

Graefen, M. ;

Perrotte, P. ;

Menon, M. ;

Montorsi, F. ;

Karakiewicz, P. I. .

ANNALS OF ONCOLOGY, 2012, 23 (04) :973-980

[4] A Phase II Trial of Sunitinib in Patients With Renal Cell Cancer and Untreated Brain Metastases [J].

Chevreau, Christine ;

Ravaud, Alain ;

Escudier, Bernard ;

Amela, Eric ;

Delva, Remy ;

Rolland, Frederic ;

Tosi, Diego ;

Oudard, Stephane ;

Blanc, Ellen ;

Ferlay, Celine ;

Negrier, Sylvie .

CLINICAL GENITOURINARY CANCER, 2014, 12 (01) :50-54

[5] Prognostic Factors for Survival of Patients With Synchronous or Metachronous Brain Metastasis of Renal Cell Carcinoma [J].

Choi, Se Young ;

Yoo, Sangjun ;

You, Dalsan ;

Jeong, In Gab ;

Song, Cheryn ;

Hong, Bumsik ;

Hong, Jun Hyuk ;

Ahn, Hanjong ;

Kim, Choung-Soo .

CLINICAL GENITOURINARY CANCER, 2017, 15 (06) :717-723

[6]

Choueiri TK., 2017, ANN ONCOL, V28, pV605, DOI [10.1093/annonc/, DOI 10.1093/ANNONC/]

[7] Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial [J].

Choueiri, Toni K. ;

Escudier, Bernard ;

Powles, Thomas ;

Tannir, Nizar M. ;

Mainwaring, Paul N. ;

Rini, Brian I. ;

Hammers, Hans J. ;

Donskov, Frede ;

Roth, Bruce J. ;

Peltola, Katriina ;

Lee, Jae Lyun ;

Heng, Daniel Y. C. ;

Schmidinger, Manuela ;

Agarwal, Neeraj ;

Sternberg, Cora N. ;

McDermott, David F. ;

Aftab, Dana T. ;

Hessel, Colin ;

Old, Christian Scheff ;

Schwab, Gisela ;

Hutson, Thomas E. ;

Pal, Sumanta ;

Motzer, Robert J. .

LANCET ONCOLOGY, 2016, 17 (07) :917-927

[8]

Culine S, 1998, CANCER-AM CANCER SOC, V83, P2548, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2548::AID-CNCR21>3.3.CO

[9]

2-W

[10]

de Liano AG, 2018, J CLIN ONCOL S, V36

← 1 2 3 →